Fetal Jeopardy and Congenital Anomalies Study
The Combination of Biochemical Markers and Two & Three-Dimensional Ultrasound Using Geometric Morphometrics in the Identification of Fetal Jeopardy and Congenital Anomalies
Protocol ID
Protocol Description
The purpose of the study is to evaluate whether a combination of blood tests, early ultrasound, and 3D ultrasound of the face at 20 weeks gestation can identify fetuses with congenital anomalies, and predict maternal or fetal complications. The other purpose of the study is to determine if screening for chromosomal disorders at the 20 weeks ultrasound is no longer necessary, if all tests before that are normal. With the exception of a 3D image of the face, both the blood tests and the 2D ultrasounds are a standard part of obstetrical care.
Eligibility Criteria
Pregnant women scheduled to have a routine second trimester ultrasound performed
Primary Investigator(s)
- Burton Rochelson, MD